Relationship Between Trans Fatty Acid (TFA) Consumption and Development of Obesity and/or Diabetes
The primary objective of this project is twofold. First, it seeks to elucidate the mechanistic link between trans fatty acid (TFA) consumption and the pathogenesis of obesity and/or diabetes, focusing on the lipotoxic cascades induced by elaidic acid as a representative industrial TFA model. Second, it investigates a targeted phytotherapeutic intervention designed to mitigate these metabolic derangements and restore physiological homeostasis.
How to Cite
1. Girard, J. (2003). Rôle des acides gras libres dans la sécrétion et l'action de l'insuline : Mécanismes de la lipotoxicité [Role of free fatty acids in insulin secretion and action: Mechanisms of lipotoxicity]. Médecine Sciences, 19(8–9), 827–833. https://doi.org/10.1051/medsci/20031989827
2. McGarry, J. D. (2002). Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes, 51(1), 7–18. https://doi.org/10.2337/diabetes.51.1.7
3. McGarry, J. D. (1992). What if Minkowski had been ageusic? An alternative angle on diabetes. Science, 258(5083), 766–770. https://doi.org/10.1126/science.1439783
4. Randle, P. J., Kerbey, A. L., & Espinal, J. (1988). Mechanisms decreasing glucose oxidation in diabetes and starvation: Role of lipid fuels and hormones. Diabetes/Metabolism Reviews, 4(7), 623–638. https://doi.org/10.1002/dmr.5610040702
5. Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. The Journal of Clinical Investigation, 106(2), 171–176. https://doi.org/10.1172/JCI10583
6. Unger, R. H. (2003). The physiology of cellular liporegulation. Annual Review of Physiology, 65, 333–347. https://doi.org/10.1146/annurev.physiol.65.092101.142622
7. Unger, R. H. (1995). Lipotoxicity in the pathogenesis of obesity-dependent NIDDM: Genetic and clinical implications. Diabetes, 44(8), 863–870. https://doi.org/10.2337/diab.44.8.863
NAJFNR is licensed under